ADIPOQ and metabolic dysfunction-associated steatohepatitis: As adiponectin and leptin exert antagonistic effects on liver fibrogenesis and inflammation, the ratio of adiponectin to leptin may be a better marker for distinguishing NASH from NAFLD.